Supplier
ASTRAZENECA S A
R/211208570010
DEIRUPEcrawl4aiMapsIMPO
$ 557.678.352
Total received
- Contracts
- 1.676
- Agencies that bought from them
- 73
- Average contract
- $ 332.744
- Years with activity
- 24
- First contract
- 24 may. 2002
- Last contract
- 24 jul. 2025
ASTRAZENECA S A received $ 558 M from the Uruguayan state across 1.676 awards between 2002 and 2025. It sold to 73 agencies. Its largest buyer is Dirección General de la Salud, with 19% of recorded spending.
What it bid for, and against whom
Open data publishes only the winner, so losing bids appear nowhere. This comes from the bidders each purchase record publishes. It covers the 11 calls of this company we have checked so far, not all of them: the scan advances gradually.
4/11won of those checked
36%win rate
17.7rivals per call, on average
Who it meets most often
- LABORATORIOS CELSIUS S A11 times
- MEGALABS URUGUAY S A10 times
- GRAMON BAGO DE URUGUAY S A9 times
- ICU VITA S A8 times
- LABORATORIO GADOR S A7 times
- URUFARMA S.A.7 times
- EUROFARMA URUGUAY SOCIEDAD ANONIMA6 times
- FARMACO URUGUAYO S.A.6 times
State Suppliers Registry (RUPE)
ACTIVO- Legal name
- ASTRAZENECA S A
- Fiscal domicile
- Montevideo YAGUARON 1407 Apto. 1205 View on Google Maps
Source: ARCE — Registro Único de Proveedores del Estado (RUPE), open data. Cross-referenced to the supplier by RUT.
Revenue by year
Who buys from them
Agencies ranked by amount awarded to this supplier.
- Dirección General de la Salud$ 507 M
- Instituto del Niño y Adolescente del Uruguay INAU-INAME)$ 22,6 M
- NO VIGENTE Centro Hospitalario Pereira Rossell$ 19,5 M
- Dirección Nacional de Sanidad Policial$ 14,9 M
Client concentration
19%
Dirección General de la Salud
How much of their revenue comes from their largest buyer.
Contracts
View all| Subject | Agency | Date | Amount |
|---|---|---|---|
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 24 jul. 2025 | $ 926.802 |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 23 jul. 2025 | $ 1,9 M |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 16 jul. 2025 | $ 926.802 |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 14 jul. 2025 | $ 926.802 |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 11 jul. 2025 | $ 1,2 M |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 23 jun. 2025 | $ 1,2 M |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 17 jun. 2025 | $ 926.802 |
| ECULIZUMAB (INYECTABLE) | Dirección General de la Salud | 17 jun. 2025 | $ 1,2 M |
1.677 suppliers